Close Menu
Home » Using NGS as CDx Will Require Paradigm Shift, Regulatory Changes, According to Experts at AACR

Using NGS as CDx Will Require Paradigm Shift, Regulatory Changes, According to Experts at AACR

Apr 16, 2014
|
Monica Heger
Premium

Next-generation sequencing holds promise for use in companion diagnostics, but will require a paradigm shift as well as changes to the regulatory landscape, according to a number of experts that presented at last week's American Association for Cancer Research meeting in San Diego.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Oh, You're Aging Well

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

Unexpected Close

GenomeWeb reports that Veritas Genetics is suspending its US operations.

Sweet Assembly

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Science Papers Describe MicroRNA Targeting Efficiency, Approach for Single-Cell High-Throughput Chemical Screens

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

What's Popular?

In Clinical Sequencing

  1. Gene Panel Finds Pathogenic Variants Missed by Standard Tests in 5 Percent of Familial Cancer Cases

  2. Illumina, ArcherDx Expand Partnership on NGS IVD Tests

  3. Childhood Kidney Cancer Arises From Altered Normal Tissue, Sequencing Study Finds

  4. Investment Banks Initiate Coverage of Centogene With Bullish Outlooks

  5. SciLifeLab Researchers Develop Multiplexed Library Prep Method for FFPE Samples

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.